The Inato Innovation Board

Our Mission Statement:

The Inato Innovation Board was born from our history of co-developing our product with sponsor collaborators and research sites to create shared value across the ecosystem. The Innovation Board is an evolution of this co-development, bringing together pharmaceutical leaders with a shared vision of deepening collaboration with community sites to unlock access to and increase the speed of clinical research. The group’s aim is to drive significant advancements in the clinical research ecosystem through innovative ideas and new technology, fostering a more transparent and efficient collaboration between sites and sponsors.
AbbVie

Bardia Akbari

Vice President Development Operation - Oncology

Sanofi

Kim Hawkins

Global Head of Clinical Project Operations

Amgen

Charisa Scott 

Senior Manager, Patient Recruitment and Retention

AstraZeneca

Michele Teufel 

Senior Director, TA Strategy & Portfolio Delivery, SM&M

Pfizer

Brian Oat

Regional Intelligence Head

Eli Lilly

Teri Breedlove

Sr Director, Clin Central Services and Innovation

Cerevel

Laura Whitmore

Senior Director, Clinical Operations, Oversight

Twoja Przychodnia Medical Center

Agata Bednarek, MD, PhD

Site Director

BRCR Global

Vaneska Chacin, MD

Director Clinical Operations

Yuma Clinical Trials

Dan Sfera

Site Director and Co-Founder

Twoja Przychodnia Medical Center

Jakub Jaszczak

Clinical Research Manager

Beautiful Minds Research

Gabriela Marinello

Chief Executive Officer